Influence of fry color on quality of coated broiler thighs von LANE, RALPH H., JONES, SHARMAN W.

Volltext

VISCOSITY AND PICKUP OF A FISH AND CHIP BATTER: DETERMINANTS OF VARIATION von LANE, RALPH H., ABDEL-GHANY, MOHAMED, JONES, SHARMAN W.

Volltext

Effect of coating type on yield, fry time and composition of broiler parts prepared in a household fryer von Lane, R.H, Jones, S.W, Abdel-Ghany, M

Volltext

Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience von O'Brien, Susan, Furman, Richard R., Coutre, Steven, Flinn, Ian W., Burger, Jan A., Blum, Kristie, Sharman, Jeff, Wierda, William, Jones, Jeffrey, Zhao, Weiqiang, Heerema, Nyla A., Johnson, Amy J., Luan, Ying, James, Danelle F., Chu, Alvina D., Byrd, John C.

Volltext

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia von Byrd, John C, Furman, Richard R, Coutre, Steven E, Flinn, Ian W, Burger, Jan A, Blum, Kristie A, Grant, Barbara, Sharman, Jeff P, Coleman, Morton, Wierda, William G, Jones, Jeffrey A, Zhao, Weiqiang, Heerema, Nyla A, Johnson, Amy J, Sukbuntherng, Juthamas, Chang, Betty Y, Clow, Fong, Hedrick, Eric, Buggy, Joseph J, James, Danelle F, O'Brien, Susan

Volltext

Autism and increased paternal age related changes in global levels of gene expression regulation von Alter, Mark D, Kharkar, Rutwik, Ramsey, Keri E, Craig, David W, Melmed, Raun D, Grebe, Theresa A, Bay, R Curtis, Ober-Reynolds, Sharman, Kirwan, Janet, Jones, Josh J, Turner, J Blake, Hen, Rene, Stephan, Dietrich A

Volltext

Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes von Dubovsky, Jason A., Beckwith, Kyle A., Natarajan, Gayathri, Woyach, Jennifer A., Jaglowski, Samantha, Zhong, Yiming, Hessler, Joshua D., Liu, Ta-Ming, Chang, Betty Y., Larkin, Karilyn M., Stefanovski, Matthew R., Chappell, Danielle L., Frissora, Frank W., Smith, Lisa L., Smucker, Kelly A., Flynn, Joseph M., Jones, Jeffrey A., Andritsos, Leslie A., Maddocks, Kami, Lehman, Amy M., Furman, Richard, Sharman, Jeff, Mishra, Anjali, Caligiuri, Michael A., Satoskar, Abhay R., Buggy, Joseph J., Muthusamy, Natarajan, Johnson, Amy J., Byrd, John C.

Volltext

Adenocarcinoma of the distal esophagus and esophageal-proventricular junction in a yellow-naped parrot von Hines, Elizabeth S., Jones, Sydney, Hoppes, Sharman, Stranahan, Lauren W.

Volltext

Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS) von Morschhauser, Franck, Flinn, Ian W, Advani, Ranjana, Sehn, Laurie H, Diefenbach, Catherine, Kolibaba, Kathryn, Press, Oliver W, Salles, Gilles, Tilly, Hervé, Chen, Andy I, Assouline, Sarit, Cheson, Bruce D, Dreyling, Martin, Hagenbeek, Anton, Zinzani, Pier Luigi, Jones, Surai, Cheng, Ji, Lu, Dan, Penuel, Elicia, Hirata, Jamie, Wenger, Michael, Chu, Yu-Waye, Sharman, Jeff

Volltext

Selective approach to preoperative echocardiography in esophageal atresia von Tanny, Sharman P. Tan, King, Sebastian K., Comella, Assia, Hawley, Alisa, Brooks, Jo-Anne, Hunt, Rod W., Jones, Bryn, Teague, Warwick J.

Volltext

The Concise Guide to PHARMACOLOGY 2013/14: Overview von Alexander, Stephen P.H., Benson, Helen E., Faccenda, Elena, Pawson, Adam J., Sharman, Joanna L., McGrath, John C., Catterall, William A., Spedding, Michael, Peters, John A., Harmar, Anthony J.

Volltext

Extended Treatment with Single-Agent Ibrutinib at the 420 mg Dose Leads to Durable Responses in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma von Coutré, Steven E, Furman, Richard R, Flinn, Ian W, Burger, Jan A, Blum, Kristie, Sharman, Jeff, Jones, Jeffrey, Wierda, William, Zhao, Weiqiang, Heerema, Nyla A, Johnson, Amy J, Tran, Anh, Zhou, Cathy, Bilotti, Elizabeth, James, Danelle F, Byrd, John C, O'Brien, Susan

Volltext

IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels von Harmar, Anthony J, Hills, Rebecca A, Rosser, Edward M, Jones, Martin, Buneman, O. Peter, Dunbar, Donald R, Greenhill, Stuart D, Hale, Valerie A, Sharman, Joanna L, Bonner, Tom I, Catterall, William A, Davenport, Anthony P, Delagrange, Philippe, Dollery, Colin T, Foord, Steven M, Gutman, George A, Laudet, Vincent, Neubig, Richard R, Ohlstein, Eliot H, Olsen, Richard W, Peters, John, Pin, Jean-Philippe, Ruffolo, Robert R, Searls, David B, Wright, Mathew W, Spedding, Michael

Volltext

Is selective echocardiography in duodenal atresia the future standard of care? von Khan, Abid, Tanny, Sharman Tan, Perkins, Elizabeth J., Hunt, Rodney W., Hutson, John M., King, Sebastian K., Jones, Bryn, Teague, Warwick J.

Volltext

Temporal Profiles of Lymphocyte Subsets and the Correlation with Infectious Events in Idelalisib-Treated Patients von Sharman, Jeffrey P., Salles, Gilles A., Jurczak, Wojciech, Jones, Jeffrey, Owen, Carolyn J., Munugalavadla, Veerendra, Dreiling, Lyndah K., Xiao, Yuanyuan, Rao, Arati V., Flinn, Ian W., O'Brien, Susan M.

Volltext

Updated Results of a Phase II Randomized Study (ROMULUS) of Polatuzumab Vedotin or Pinatuzumab Vedotin Plus Rituximab in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma von Morschhauser, Franck, Flinn, Ian, Advani, Ranjana H, Diefenbach, Catherine S., Kolibaba, Kathryn, Press, Oliver W., Sehn, Laurie H, Chen, Andy I, Salles, Gilles, Tilly, Herve, Cheson, Bruce D., Assouline, Sarit, Dreyling, Martin, Hagenbeek, Anton, Zinzani, Pier Luigi, Yalamanchili, Sreeni, Lu, Dan, Jones, Cheryl, Jones, Surai, Chu, Yu-Waye, Sharman, Jeff P.

Volltext

Five-Year Experience with Single-Agent Ibrutinib in Patients with Previously Untreated and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia von O'Brien, Susan M., Furman, Richard R., Coutre, Steven E., Flinn, Ian W., Burger, Jan, Blum, Kristie, Sharman, Jeff, Wierda, William G., Jones, Jeffrey, Zhao, Weiqiang, Heerema, Nyla A., Johnson, Amy J., Luan, Ying, James, Danelle F., Chu, Alvina D., Byrd, John C.

Volltext

Two doses of polatuzumab vedotin (PoV, anti-CD79b antibody-drug conjugate) in patients (pts) with relapsed/refractory (RR) follicular lymphoma (FL): Durable responses at lower dose... von Advani, Ranjana H., Flinn, Ian, Sharman, Jeff Porter, Magid Diefenbach, Catherine S., Kolibaba, Kathryn S., Press, Oliver W., Sehn, Laurie Helen, Chen, Andy I., Salles, Gilles A., Tilly, Herve, Cheson, Bruce D., Assouline, Sarit E., Dreyling, Martin H., Hagenbeek, Anton, Zinzani, Pier Luigi, Jones, Cheryl, Chu, Yu-Waye, Hirata, Jamie, Wenger, Michael, Morschhauser, Franck

Volltext

Durable Responses Including Complete Responses in CLL Following Long Term Treatment With Single-agent Ibrutinib 420 mg von O'Brien, Susan, MD, Coutre, Steven, MD, Furman, Richard R., MD, Flinn, Ian W., MD, PhD, Burger, Jan, MD, PhD, Blum, Kristie, MD, Sharman, Jeff, MD, Jones, Jeffrey, MD, MPH, Wierda, William, MD, PhD, Zhao, Weiqiang, MD, PhD, Heerema, Nyla A., PhD, Johnson, Amy, PhD, Tran, Anh, BS, Zhou, Cathy, Bilotti, Elizabeth, MSN, James, Danelle F., MD, MAS, Byrd, John C., MD

Volltext

Long-Term Efficacy and Safety of Single-Agent Ibrutinib at 3 Years Follow-up in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL) von O’Brien, Susan M., MD, Jones, Jeffrey A., MD, MPH, Furman, Richard R., MD, Coutre, Steven E., MD, Flinn, Ian W., MD, PhD, Burger, Jan A., MD, PhD, Blum, Kristie A., MD, Sharman, Jeff P., MD, Wierda, William G., MD, PhD, Zhao, Weiqiang, MD, PhD, Heerema, Nyla A., PhD, Johnson, Amy J., PhD, Tran, Anh, BS, Zhou, Cathy, Bilotti, Elizabeth, MSN, James, Danelle F., MD, MAS, Byrd, John C., MD

Volltext